Italfarmaco Announces Topline Data from Phase 2 Trial with Givinostat in Patients with Becker
This afternoon at PPMD’s Virtual Annual Conference, Italfarmaco shared Phase II Study results from the Givinostat trial in patients with Becker. They also issued a press release below. Although they did not meet the primary…Learn More